Investigating the reason for loss-of-function of Src homology 2 domain-containing protein tyrosine phosphatase 2 (SHP2) caused by Y279C mutation through molecular dynamics simulation

References

• Balmith, M., & Soliman, M. E. (2017). Non-active site mutations disturb the loop dynamics, dimerization, viral budding and egress of VP40 of the Ebola virus. Molecular Biosystems, 13(3), 585–597. doi: 10.1039/C6MB00803H
   PubMedGoogle Scholar
• Brysbaert, G., Blossey, R., & Lensink, M. F. (2018). The inclusion of water molecules in residue interaction networks identifies additional central residues. Frontiers in Molecular Biosciences, 5, 88. doi: 10.3389/fmolb.2018.00088
   PubMed Web of Science ®Google Scholar
• Carcavilla, A., Santomé, J. L., Pinto, I., Sánchez-Pozo, J., Guillén-Navarro, E., Martín-Frías, M., … Ezquieta, B. (2013). LEOPARD syndrome: A variant of Noonan syndrome strongly associated with hypertrophic cardiomyopathy. Revista Española de Cardiología (English Edition), 66(5), 350–356. doi: 10.1016/j.rec.2012.09.015
   PubMed Web of Science ®Google Scholar
• Carugo, O., & Djinovic-Carugo, K. (2013a). Half a century of Ramachandran plots. Acta Crystallographica Section D Biological Crystallography, 69(8), 1333–1341. doi: 10.1107/S090744491301158X
   PubMedGoogle Scholar
• Carugo, O., & Djinovic-Carugo, K. (2013b). A proteomic Ramachandran plot (PRplot). Amino Acids, 44(2), 781–790. doi: 10.1007/s00726-012-1402-z
   PubMed Web of Science ®Google Scholar
• David, C. C., & Jacobs, D. J. (2014). Principal component analysis: A method for determining the essential dynamics of proteins. Methods in Molecular Biology, 1084, 193–226. doi: 10.1007/978-1-62703-658-0_11
   PubMedGoogle Scholar
• Farrokhzadeh, A., Akher, F. B., & Soliman, M. E. S. (2018). Probing the dynamic mechanism of uncommon allosteric inhibitors optimized to enhance drug selectivity of SHP2 with therapeutic potential for cancer treatment. Applied Biochemistry and Biotechnology, 188(1), 260–281. doi: 10.1007/s12010-018-2914-0
   PubMed Web of Science ®Google Scholar
• Garcia Fortanet, J., Chen, C. H.-T., Chen, Y.-N. P., Chen, Z., Deng, Z., Firestone, B., … LaMarche, M. J. (2016). Allosteric Inhibition of SHP2: Identification of a potent, selective, and orally efficacious phosphatase inhibitor. Journal of Medicinal Chemistry, 59(17), 7773–7782. doi: 10.1021/acs.jmedchem.6b00680
   PubMed Web of Science ®Google Scholar
• Grant, B. J., Rodrigues, A. P., ElSawy, K. M., McCammon, J. A., & Caves, L. S. (2006). Bio3d: An R package for the comparative analysis of protein structures. Bioinformatics, 22(21), 2695–2696. doi: 10.1093/bioinformatics/btl461
   PubMed Web of Science ®Google Scholar
• Hanna, N., Montagner, A., Lee, W. H., Miteva, M., Vidal, M., Vidaud, M., … Raynal, P. (2006). Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: Consequences for PI3K binding on Gab1. FEBS Letters, 580(10), 2477–2482. doi: 10.1016/j.febslet.2006.03.088
   PubMed Web of Science ®Google Scholar
• Hatmal, M. M., Jaber, S., & Taha, M. O. (2016). Combining molecular dynamics simulation and ligand–receptor contacts analysis as a new approach for pharmacophore modeling: Beta-secretase 1 and check point kinase 1 as case studies. Journal of Computer-Aided Molecular Design, 30(12), 1149–1163. doi: 10.1007/s10822-016-9984-2
   PubMed Web of Science ®Google Scholar
• Hess, B. (2008). P-LINCS: A parallel linear constraint solver for molecular simulation. Journal of Chemical Theory and Computation, 4(1), 116–122. doi: 10.1021/ct700200b
   PubMed Web of Science ®Google Scholar
• Hof, P., Pluskey, S., Dhe-Paganon, S., Eck, M. J., & Shoelson, S. E. (1998). Crystal structure of the tyrosine phosphatase SHP-2. Cell, 92(4), 441–450.
   PubMed Web of Science ®Google Scholar
• Ishida, H., Kogaki, S., Narita, J., Ichimori, H., Nawa, N., Okada, Y., … Ozono, K. (2011). LEOPARD-type SHP2 mutant Gln510Glu attenuates cardiomyocyte differentiation and promotes cardiac hypertrophy via dysregulation of Akt/GSK-3beta/beta-catenin signaling. American Journal of Physiology-Heart and Circulatory Physiology, 301(4), H1531–1539. doi: 10.1152/ajpheart.00216.2011
   PubMed Web of Science ®Google Scholar
• Ishikita, H., & Saito, K. (2013). Proton transfer reactions and hydrogen-bond networks in protein environments. Journal of the Royal Society Interface, 11(91), 20130518. doi: 10.1098/rsif.2013.0518
   PubMed Web of Science ®Google Scholar
• Kan, W., Fang, F., Chen, L., Wang, R., & Deng, Q. (2016). Influence of the R823W mutation on the interaction of the ANKS6–ANKS3: Insights from molecular dynamics simulation and free energy analysis. Journal of Biomolecular Structure and Dynamics, 34(5), 1113–1122. doi: 10.1080/07391102.2015.1071281
   PubMed Web of Science ®Google Scholar
• Keren, B., Hadchouel, A., Saba, S., Sznajer, Y., Bonneau, D., Leheup, B, … French Collaborative Noonan Study, Group. (2004). PTPN11 mutations in patients with LEOPARD syndrome: A French multicentric experience. Journal of Medical Genetics, 41(11), e117. doi: 10.1136/jmg.2004.021451
   PubMed Web of Science ®Google Scholar
• Kumar, P., Ghosh Sachan, S., & Poddar, R. (2017). Mutational analysis of microbial hydroxycinnamoyl-CoA hydratase-lyase (HCHL) towards enhancement of binding affinity: A computational approach. Journal of Molecular Graphics and Modelling, 77, 94–105. doi: 10.1016/j.jmgm.2017.08.014
   PubMed Web of Science ®Google Scholar
• Li, H. L., Ma, Y., Zheng, C. J., Jin, W. Y., Liu, W. S., & Wang, R. L. (2017). Exploring the effect of D61G mutation on SHP2 cause gain of function activity by a molecular dynamics study. Journal of Biomolecular Structure and Dynamics, 36(14), 3856–3868. doi: 10.1080/07391102.2017.1402709
   Web of Science ®Google Scholar
• Li, J., Bewley, J. D., Hua, Z., Zheng, W., & Wang, A. (2008). Model and molecular dynamic simulations of active and inactive endo-beta-1,4-mannanase in tomato fruit. The Protein Journal, 27(6), 363–370. doi: 10.1007/s10930-008-9145-0
   PubMed Web of Science ®Google Scholar
• Li, R., Baskfield, A., Lin, Y., Beers, J., Zou, J., Liu, C., … Zheng, W. (2019). Generation of an induced pluripotent stem cell line (TRNDi003-A) from a Noonan syndrome with multiple lentigines (NSML) patient carrying a p.Q510P mutation in the PTPN11 gene. Stem Cell Research, 34, 101374. doi: 10.1016/j.scr.2018.101374
   PubMed Web of Science ®Google Scholar
• Li, X., Wang, X., Tian, Z., Zhao, H., Liang, D., Li, W., … Lu, S. (2014). Structural basis of valmerins as dual inhibitors of GSK3beta/CDK5. Journal of Molecular Modeling, 20(9), 2407. doi: 10.1007/s00894-014-2407-1
   PubMed Web of Science ®Google Scholar
• Limongelli, G., Pacileo, G., Marino, B., Digilio, M. C., Sarkozy, A., Elliott, P., … Calabro, R. (2007). Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome. The American Journal of Cardiology, 100(4), 736–741. doi: 10.1016/j.amjcard.2007.03.093
   PubMed Web of Science ®Google Scholar
• Machaba, K. E., Mhlongo, N. N., & Soliman, M. E. S. (2018). Induced mutation proves a potential target for TB therapy: A molecular dynamics study on LprG. Cell Biochemistry and Biophysics, 76(3), 345–356. doi: 10.1007/s12013-018-0852-7
   PubMed Web of Science ®Google Scholar
• Mahmoodi, Y., Mehrnejad, F., & Khalifeh, K. (2018). Understanding the interactions of human follicle stimulating hormone with single-walled carbon nanotubes by molecular dynamics simulation and free energy analysis. European Biophysics Journal, 47(1), 49–57. doi: 10.1007/s00249-017-1228-4
   PubMed Web of Science ®Google Scholar
• Martinez-Quintana, E., & Rodriguez-Gonzalez, F. (2012). LEOPARD syndrome: Clinical features and gene mutations. Molecular Syndromology, 3(4), 145–157, doi: 10.1159/000342251
   PubMedGoogle Scholar
• Mehla, K., & Ramana, J. (2016). Travelers' diarrhea-associated enterotoxigenic Escherichia coli gyrA mutants and quinolone antibiotic affinity: A molecular dynamics simulation and residue interaction network analysis. OMICS, 20(11), 635–644. doi: 10.1089/omi.2016.0104
   PubMed Web of Science ®Google Scholar
• Moglich, A., Joder, K., & Kiefhaber, T. (2006). End-to-end distance distributions and intrachain diffusion constants in unfolded polypeptide chains indicate intramolecular hydrogen bond formation. Proceedings of the National Academy of Sciences of the United States of America, 103(33), 12394–12399. doi: 10.1073/pnas.0604748103
   PubMed Web of Science ®Google Scholar
• Narang, S. S., Shuaib, S., Goyal, D., & Goyal, B. (2018). Assessing the effect of D59P mutation in the DE loop region in amyloid aggregation propensity of beta2-microglobulin: A molecular dynamics simulation study. Journal of Cellular Biochemistry, 119(1), 782–792. doi: 10.1002/jcb.26241
   PubMed Web of Science ®Google Scholar
• Ndagi, U., Mhlongo, N. N., & Soliman, M. E. (2017). The impact of Thr91 mutation on c-Src resistance to UM-164: Molecular dynamics study revealed a new opportunity for drug design. Molecular Biosystems, 13(6), 1157–1171. doi: 10.1039/C6MB00848H
   PubMed Web of Science ®Google Scholar
• Neel, B. G., Gu, H., & Pao, L. (2003). The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends in Biochemical Sciences, 28(6), 284–293. doi: 10.1016/S0968-0004(03)00091-4
   PubMed Web of Science ®Google Scholar
• Niu, Y., Shi, D., Li, L., Guo, J., Liu, H., & Yao, X. (2017). Revealing inhibition difference between PFI-2 enantiomers against SETD7 by molecular dynamics simulations, binding free energy calculations and unbinding pathway analysis. Scientific Reports, 7(1), 46547. doi: 10.1038/srep46547
   PubMedGoogle Scholar
• Noda, S., Takahashi, A., Hayashi, T., Tanuma, S., & Hatakeyama, M. (2016). Determination of the catalytic activity of LEOPARD syndrome-associated SHP2 mutants toward parafibromin, a bona fide SHP2 substrate involved in Wnt signaling. Biochemical and Biophysical Research Communications, 469(4), 1133–1139. doi: 10.1016/j.bbrc.2015.12.117
   PubMed Web of Science ®Google Scholar
• Paardekooper Overman, J., Preisinger, C., Prummel, K., Bonetti, M., Giansanti, P., Heck, A., & den Hertog, J. (2014). Phosphoproteomics-mediated identification of Fer kinase as a target of mutant Shp2 in Noonan and LEOPARD syndrome. PLoS One, 9(9), e106682. doi: 10.1371/journal.pone.0106682
   PubMed Web of Science ®Google Scholar
• Pal, D., & Chakrabarti, P. (2002). On residues in the disallowed region of the Ramachandran map. Biopolymers, 63(3), 195–206. doi: 10.1002/bip.10051
   PubMed Web of Science ®Google Scholar
• Park, I. H., Venable, J. D., Steckler, C., Cellitti, S. E., Lesley, S. A., Spraggon, G., & Brock, A. (2015). Estimation of hydrogen-exchange protection factors from MD simulation based on amide hydrogen bonding analysis. Journal of Chemical Information and Modeling, 55(9), 1914–1925. doi: 10.1021/acs.jcim.5b00185
   PubMed Web of Science ®Google Scholar
• Pei, D., Wang, J., & Walsh, C. T. (1996). Differential functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1. Proceedings of the National Academy of Sciences of the United States of America, 93(3), 1141–1145. doi: 10.1073/pnas.93.3.1141
   PubMed Web of Science ®Google Scholar
• Rashid, S., Saraswathi, S., Kloczkowski, A., Sundaram, S., & Kolinski, A. (2016). Protein secondary structure prediction using a small training set (compact model) combined with a complex-valued neural network approach. BMC Bioinformatics, 17(1), 362. doi: 10.1186/s12859-016-1209-0
   PubMedGoogle Scholar
• Sarkozy, A., Digilio, M. C., & Dallapiccola, B. (2008). Leopard syndrome. Orphanet Journal of Rare Diseases, 3(1), 13. doi: 10.1186/1750-1172-3-13
   PubMedGoogle Scholar
• Sigala, P. A., Ruben, E. A., Liu, C. W., Piccoli, P. M. B., Hohenstein, E. G., Martínez, T. J., … Herschlag, D. (2015). Determination of hydrogen bond structure in water versus aprotic environments to test the relationship between length and stability. Journal of the American Chemical Society, 137(17), 5730–5740. doi: 10.1021/ja512980h
   PubMed Web of Science ®Google Scholar
• Spatola, M., Wider, C., Kuntzer, T., & Croquelois, A. (2015). PTPN11 mutation manifesting as LEOPARD syndrome associated with hypertrophic plexi and neuropathic pain. BMC Neurology, 15(1), 55. doi: 10.1186/s12883-015-0310-8
   PubMedGoogle Scholar
• Sun, D. R., Zheng, Q. C., & Zhang, H. X. (2017). Probing the interaction mechanism of small molecule inhibitors with matriptase based on molecular dynamics simulation and free energy calculations. Journal of Biomolecular Structure and Dynamics, 35(4), 755–764. doi: 10.1080/07391102.2016.1160259
   PubMed Web of Science ®Google Scholar
• Tajan, M., Batut, A., Cadoudal, T., Deleruyelle, S., Le Gonidec, S., Saint Laurent, C., … Yart, A. (2014). LEOPARD syndrome-associated SHP2 mutation confers leanness and protection from diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America, 111(42), E4494–E4503. doi: 10.1073/pnas.1406107111
   PubMed Web of Science ®Google Scholar
• Takano, Y., Nakata, K., Yonezawa, Y., & Nakamura, H. (2016). Development of massive multilevel molecular dynamics simulation program, Platypus (PLATform for dYnamic Protein Unified Simulation), for the elucidation of protein functions. Journal of Computational Chemistry, 37(12), 1125–1132. doi: 10.1002/jcc.24318
   PubMed Web of Science ®Google Scholar
• Ul Haq, F., Abro, A., Raza, S., Liedl, K. R., & Azam, S. S. (2017). Molecular dynamics simulation studies of novel beta-lactamase inhibitor. Journal of Molecular Graphics and Modelling, 74, 143–152. doi: 10.1016/j.jmgm.2017.03.002
   PubMed Web of Science ®Google Scholar
• Vermeire, K., Wexler, L., & Vambutas, A. (2016). The experience of bilateral cochlear implantation in a child with LEOPARD syndrome. International Journal of Pediatric Otorhinolaryngology, 90, 125–127. doi: 10.1016/j.ijporl.2016.09.013
   PubMed Web of Science ®Google Scholar
• Wan, H., Hu, J. P., Tian, X. H., & Chang, S. (2013). Molecular dynamics simulations of wild type and mutants of human complement receptor 2 complexed with C3d. Physical Chemistry Chemical Physics, 15(4), 1241–1251. doi: 10.1039/C2CP41388D
   PubMed Web of Science ®Google Scholar
• Wang, J., Shu, M., Wang, Y., Hu, Y., Wang, Y., Luo, Y., & Lin, Z. (2016). Identification of potential CCR5 inhibitors through pharmacophore-based virtual screening, molecular dynamics simulation and binding free energy analysis. Molecular Biosystems, 12(11), 3396–3406. doi: 10.1039/C6MB00577B
   PubMedGoogle Scholar
• Wang, R. R., Ma, Y., Du, S., Li, W. Y., Sun, Y. Z., Zhou, H., & Wang, R. L. (2019). Exploring the reason for increased activity of SHP2 caused by D61Y mutation through molecular dynamics. Computational Biology and Chemistry, 78, 133–143. doi: 10.1016/j.compbiolchem.2018.10.013
   PubMed Web of Science ®Google Scholar
• Webb, B., & Sali, A. (2016). Comparative protein structure modeling using MODELLER. Current Protocols in Protein Science, 86, 2.9.1–2.9.37. doi: 10.1002/cpps.20
   PubMedGoogle Scholar
• Xu, L., Kong, R., Zhu, J., Sun, H., & Chang, S. (2016). Unraveling the conformational determinants of LARP7 and 7SK small nuclear RNA by theoretical approaches. Molecular Biosystems, 12(8), 2613–2621. doi: 10.1039/C6MB00252H
   PubMedGoogle Scholar
• Xue, W., Ban, Y., Liu, H., & Yao, X. (2014a). Computational study on the drug resistance mechanism against HCV NS3/4A protease inhibitors vaniprevir and MK-5172 by the combination use of molecular dynamics simulation, residue interaction network, and substrate envelope analysis. Journal of Chemical Information and Modeling, 54(2), 621–633. doi: 10.1021/ci400060j
   PubMed Web of Science ®Google Scholar
• Xue, W., Jiao, P., Liu, H., & Yao, X. (2014b). Molecular modeling and residue interaction network studies on the mechanism of binding and resistance of the HCV NS5B polymerase mutants to VX-222 and ANA598. Antiviral Research, 104, 40–51. doi: 10.1016/j.antiviral.2014.01.006
   PubMed Web of Science ®Google Scholar
• Yang, Y., Gao, J., Wang, J., Heffernan, R., Hanson, J., Paliwal, K., & Zhou, Y. (2018). Sixty-five years of the long march in protein secondary structure prediction: The final stretch? Briefings in Bioinformatics, 19(3), 482–494. doi: 10.1093/bib/bbw129
   PubMed Web of Science ®Google Scholar
• Yang, Y., Liu, H., & Yao, X. (2012). Understanding the molecular basis of MK2-p38alpha signaling complex assembly: Insights into protein-protein interaction by molecular dynamics and free energy studies. Molecular Biosystems, 8(8), 2106–2118. doi: 10.1039/c2mb25042j
   PubMedGoogle Scholar
• Yesudhas, D., Anwar, M. A., Panneerselvam, S., Durai, P., Shah, M., & Choi, S. (2016). Structural mechanism behind distinct efficiency of Oct4/Sox2 proteins in differentially spaced DNA complexes. PLoS One, 11(1), e0147240. doi: 10.1371/journal.pone.0147240
   PubMed Web of Science ®Google Scholar
• Yu, Z.-H., Xu, J., Walls, C. D., Chen, L., Zhang, S., Zhang, R., … Zhang, Z.-Y. (2013). Structural and mechanistic insights into LEOPARD syndrome-associated SHP2 mutations. Journal of Biological Chemistry, 288(15), 10472–10482. doi: 10.1074/jbc.M113.450023
   PubMed Web of Science ®Google Scholar
• Yu, Z.-H., Zhang, R.-Y., Walls, C. D., Chen, L., Zhang, S., Wu, L., … Zhang, Z.-Y. (2014). Molecular basis of gain-of-function LEOPARD syndrome-associated SHP2 mutations. Biochemistry, 53(25), 4136–4151. doi: 10.1021/bi5002695
   PubMed Web of Science ®Google Scholar
• Zhang, L. (2017). Different dynamics and pathway of disulfide bonds reduction of two human defensins, a molecular dynamics simulation study. Proteins: Structure, Function, and Bioinformatics, 85(4), 665–681. doi: 10.1002/prot.25247
   PubMed Web of Science ®Google Scholar
• Zhang, Y. J., Ding, J. N., Zhong, H., & Han, J. G. (2017). Exploration micromechanism of VP35 IID interaction and recognition dsRNA: A molecular dynamics simulation. Proteins: Structure, Function, and Bioinformatics, 85(6), 1008–1023. doi: 10.1002/prot.25269
   PubMed Web of Science ®Google Scholar
• Zhang, Y., & Sagui, C. (2015). Secondary structure assignment for conformationally irregular peptides: Comparison between DSSP, STRIDE and KAKSI. Journal of Molecular Graphics and Modelling, 55, 72–84. doi: 10.1016/j.jmgm.2014.10.005
   PubMed Web of Science ®Google Scholar
• Zhou, Y., Zhang, N., Chen, W., Zhao, L., & Zhong, R. (2016). Underlying mechanisms of cyclic peptide inhibitors interrupting the interaction of CK2alpha/CK2beta: Comparative molecular dynamics simulation studies. Physical Chemistry Chemical Physics, 18(13), 9202–9210. doi: 10.1039/C5CP06276D
   PubMed Web of Science ®Google Scholar